1536
P. S. Reddy, G. V. M. Sharma
PAPER
IR (CHCl3): 3481, 2988, 2938, 2886, 1455, 1379, 1243, 1213, 1152,
1110, 1019, 916, 867, 814, 753, 700, 667 cm–1.
4.08 (d, J = 7.9 Hz, 1 H, allylic OCH), 3.74 (d, J = 10.2 Hz, 1 H,
OCH), 3.58 (d, J = 10.2 Hz, 1 H, OCH′), 3.34 (s, 3 H, OCH3), 3.26
(s, 3 H, OCH3), 1.61 (s, 3 H, CH3), 1.41 (s, 3 H, CH3).
13C NMR (75 MHz, CDCl3): δ = 137.7, 133.4, 128.2 (2 C), 127.7 (2
C), 127.6, 119.9, 113.9, 104.9, 96.6, 93.8, 88.7, 87.3, 85.2, 78.6,
72.2, 68.0, 55.6, 55.2, 28.1, 27.8.
1H NMR (300 MHz, CDCl3): δ = 7.44–7.30 (m, 5 H, Ar-H), 6.0 (d,
J = 4.7 Hz, 1 H, C-1 H), 4.82 (dd, J = 3.2, 4.7 Hz, 1 H, C-2 H), 4.77
(d, J = 11.5 Hz, 1 H, OCHPh), 4.62 (dd, J = 6.4, 8.3 Hz, 2 H,
OCH2O), 4.52 (d, J = 11.5 Hz, 1 H, OCH′Ph), 3.95 (d, J = 3.2 Hz,
1 H, C-3 H), 3.91–3.80 (m, 1 H, CHOH), 3.75 (d, J = 10.2 Hz, 1 H,
OCH), 3.65–3.55 (m, 1 H, CH′OH), 3.54 (d, J = 10.2 Hz, 1 H,
OCH′), 3.31 (s, 3 H, OCH3), 3.22 (d, J = 2.7 Hz, 1 H, epoxy CH),
3.03–2.98 (m, 1 H, epoxy CH′), 1.57 (s, 3 H, CH3), 1.42 (s, 3 H,
CH3).
13C NMR (75 MHz, CDCl3): δ = 137.1, 128.2 (2 C), 127.7, 127.6 (2
C), 113.7, 104.5, 96.5, 86.9, 85.7, 83.1, 72.0, 68.0, 60.8, 55.1, 55.0
(2 C), 27.7 (2 C).
HRMS (ESI+): m/z [M + Na]+ calcd for C20H28NaO8: 419.16764;
found: 419.16601.
HRMS (ESI+): m/z [M + Na]+ calcd for C22H32NaO8: 447.19894;
found: 447.19805.
4-O-Benzyl-1,2-dideoxy-5-C-[(1R)-1-(methoxymethoxy)prop-2-
en-1-yl]-6-O-(methoxymethyl)-D-xylo-hex-1-enitol (4)
A solution of furanose 15 (1.20 g, 2.83 mmol) in 70% aq AcOH (12
mL) was stirred at 55 °C for 8 h. The mixture was neutralized with
solid NaHCO3 and then extracted with EtOAc (3 × 40 mL). The or-
ganic layer was dried (Na2SO4) and concentrated to give a residue
that was purified by column chromatography (silica gel, 40%
EtOAc–PE) to give 16 [yield: 0.69 g (63%)] as a colorless oil, along
with trace amounts of triol 17.
3-O-Benzyl-6,7-dideoxy-4-[(methoxymethoxy)methyl]-1,2-O-
(1-methylethylidene)-β-L-altro-hept-6-enofuranose (ent-5) from
14a
Ph3P (0.30 g, 1.14 mmol), imidazole (0.15 g, 2.27 mmol), and I2
(0.29 g, 1.14 mmol) were added sequentially to a solution of 14a
(0.30 g, 0.76 mmol) in anhydrous THF (5 mL) at 0 °C, and the mix-
ture was stirred for 20 min. Workup as described for 13b gave io-
dide 14b, which was used directly in the next reaction.
A suspension of Ph3P+MeBr– (2.23 g, 6.25 mmol) in anhydrous
THF (4 mL) at 0 °C was treated with a 2.5 M solution of n-BuLi in
hexane (2.09 mL, 5.21 mmol), and the mixture was stirred for 25
min. A solution of 16 (0.40 g, 1.04 mmol) in anhydrous THF (3 mL)
was added, and the resulting mixture was stirred while it warmed to
r.t. for 2 h. The mixture was then diluted with ice-cold H2O (15 mL)
and extracted with EtOAc (2 × 20 mL). The organic phases were
combined, washed with brine (10 mL), and dried (Na2SO4). The sol-
vent was evaporated under reduced pressure and the residue was pu-
rified by column chromatography (silica gel, 30% EtOAc–PE) to
To a solution of 14b (0.38 g, 0.76 mmol) in MeOH (6 mL), Zn (0.20
g, 3.03 mmol) and NaI (0.11 g, 1.14 mmol) were added and the mix-
ture was stirred at the reflux for 10 h. The solvent was evaporated
and the residue was purified by column chromatography (silica gel,
15% EtOAc–PE) to give ent-5a as a colorless oil; yield: 0.21 (72%);
[α]D27 +33.8 (c 0.25, CHCl3).
27
give 4 as a colorless oil; yield: 0.26 (65%); [α]D –86.4 (c 0.40,
CHCl3).
IR (CHCl3): 3546, 3395, 3017, 2932, 2892, 1451, 1404, 1215, 1149,
1105, 1026, 920, 746, 667 cm–1.
IR (CHCl3): 3481, 2987, 2935, 2886, 1455, 1376, 1214, 1151, 1108,
1074, 1039, 922, 865, 749, 700, 667 cm–1.
1H NMR (300 MHz, CDCl3): δ = 7.36–7.27 (m, 5 H, Ar-H), 6.12–
5.87 (m, 2 H, olefinic), 5.45–5.27 (m, 3 H, olefinic), 5.19 (ddd, J =
1.5, 3.2, 10.6 Hz, 1 H, olefinic), 4.78–4.58 (m, 7 H, OCH2Ph, 2 ×
OCH2O, allylic CH), 4.21 (d, J = 8.1 Hz, 1 H, allylic CH′), 3.84 (d,
J = 1.5 Hz, 1 H, CHOBn), 3.83 (d, J = 10.2 Hz, 1 H, OCH), 3.63 (d,
J = 10.2 Hz, 1 H, OCH′), 3.39 (s, 3 H, OCH3), 3.36 (s, 3 H, OCH3).
13C NMR (75 MHz, CDCl3): δ = 139.8, 138.2, 133.7, 128.2 (2 C),
127.6 (3 C), 120.2, 114.7, 97.2, 94.3, 81.4, 80.2, 77.3, 75.0, 70.9,
68.9, 56.1, 55.7.
1H NMR (500 MHz, CDCl3): δ = 7.39–7.27 (m, 5 H, Ar-H), 5.96 (d,
J = 4.3 Hz, 1 H, C-1 H), 5.81 (ddd, J = 6.2, 10.5, 16.8 Hz, 1 H, ole-
finic), 5.39 (d, J = 16.8 Hz, 1 H, olefinic), 5.21 (d, J = 10.5 Hz, 1 H,
olefinic), 4.83–4.78 (m, 1 H, C-2 H), 4.71 (d, J = 11.5 Hz, 1 H,
OCHPh), 4.60 (d, J = 6.2 Hz, 1 H, OCHO), 4.57 (d, J = 6.2 Hz, 1 H,
OCH′O), 4.53 (d, J = 11.5 Hz, 1 H, OCH′Ph), 4.30–4.25 (m, 2 H, C-
3 H, CHOH), 3.75 (d, J = 10.5 Hz, 1 H, OCH), 3.51 (d, J = 10.5 Hz,
1 H, OCH′), 3.29 (s, 3 H, OCH3), 2.83 (d, J = 2.4 Hz, 1 H, OH), 1.58
(s, 3 H, CH3), 1.37 (s, 3 H, CH3).
13C NMR (75 MHz, CDCl3): δ = 137.5, 134.6, 128.3 (2 C), 127.7,
127.6 (2 C), 117.6, 113.7, 104.6, 96.7, 90.6, 87.0, 82.8, 73.0, 72.1,
68.1, 55.4, 27.9, 27.6.
HRMS (ESI+): m/z [M + Na]+ calcd for C20H28NaO7: 403.17272;
found: 403.17189.
HRMS (ESI+): m/z [M + Na]+ calcd for C20H30NaO7: 405.18837;
found: 405.18718.
(1S,2R,3S,6R)-2-(Benzyloxy)-6-(methoxymethoxy)-1-[(meth-
oxymethoxy)methyl]cyclohex-4-ene-1,3-diol (18)
Grubbs II catalyst (10 mol%) was added to a solution of hexenitol 4
(0.20 g, 0.52 mmol) in anhydrous toluene (32 mL), and the mixture
was stirred at r.t. under N2 for 2 h. The mixture was then evaporated
to dryness to give a brown residue that was purified by column chro-
matography (silica gel, 35% EtOAc–PE) to give a colorless oil;
yield: 0.14 (76%); [α]D27 –3.6 (c 0.25, CHCl3).
3-O-Benzyl-6,7-dideoxy-4-[(methoxymethoxy)methyl]-5-O-
(methoxymethyl)-1,2-O-(1-methylethylidene)-α-D-galacto-hept-
6-enofuranose (15)
DIPEA (2.73 mL, 15.79 mmol) MOMCl (0.60 mL, 7.89 mmol), and
a catalytic amount of DMAP were added sequentially to a stirred
and cooled (0 °C) solution of 5 (1.50 g, 3.95 mmol) in CH2Cl2 (8
mL) at 0 °C, and the mixture was warmed to r.t. with stirring for 12
h. Workup as described for 8 and purification of the residue by col-
umn chromatography (silica gel, 15% EtOAc–PE) gave a pale-
yellow oil; yield: 1.31 (78%); [α]D27 –39.7 (c 0.48, CHCl3).
IR (CHCl3): 3436, 3032, 2927, 2889, 2852, 2825, 1453, 1400, 1215,
1146, 1096, 1029, 958, 915, 772, 746, 700, 668 cm–1.
1H NMR (300 MHz, CDCl3): δ = 7.42–7.29 (m, 5 H, Ar-H), 5.84 (d,
J = 11.7 Hz, 1 H, olefinic), 5.80 (d, J = 11.7 Hz, 1 H, olefinic), 4.84–
4.61 (m, 6 H, OCH2Ph, 2 × OCH2O), 4.47 (d, J = 6.0 Hz, 1 H, allylic
CH), 4.08 (s, 1 H, allylic CH′), 3.93 (d, J = 10.6 Hz, 1 H, OCH), 3.85
(d, J = 10.6 Hz, 1 H, OCH), 3.67 (d, J = 6.0 Hz, 1 H, CHOBn), 3.39
(s, 6 H, 2 × OCH3), 3.15–3.00 (br s, 1 H, OH).
IR (CHCl3): 3016, 2988, 2938, 2888, 1455, 1379, 1240, 1214, 1147,
1075, 1024, 918, 865, 748, 699, 667 cm–1.
1H NMR (300 MHz, CDCl3): δ = 7.40–7.27 (m, 5 H, Ar-H), 6.02 (d,
J = 4.5 Hz, 1 H, C-1 H), 5.72 (ddd, J = 7.9, 10.6, 17.0 Hz, 1 H, ole-
finic), 5.29 (d, J = 10.6 Hz, 1 H, olefinic), 5.27 (d, J = 17.0 Hz, 1 H,
olefinic), 4.84 (dd, J = 3.4, 4.5 Hz, 1 H, C-2 H), 4.76 (d, J = 11.3
Hz, 1 H, OCHPh), 4.68 (d, J = 6.8 Hz, 1 H, OCHO), 4.62–4.50 (m,
4 H, OCH′Ph, OCH′O, OCH2O), 4.17 (d, J = 3.4 Hz, 1 H, C-3 H),
13C NMR (75 MHz, CDCl3): δ = 138.1, 130.9, 128.5 (2 C), 128.0 (2
C), 127.9, 127.0, 97.6, 97.0, 81.6, 75.6 (2 C), 74.6, 70.6, 69.7, 55.7,
55.5.
HRMS (ESI+): m/z [M + Na]+ calcd for C18H26NaO7: 377.15707;
found: 377.15648.
Synthesis 2014, 46, 1532–1538
© Georg Thieme Verlag Stuttgart · New York